BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19458071)

  • 1. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.
    Fan G; Fan Y; Gupta N; Matsuura I; Liu F; Zhou XZ; Lu KP; Gélinas C
    Cancer Res; 2009 Jun; 69(11):4589-97. PubMed ID: 19458071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury.
    Kuboki S; Sakai N; Clarke C; Schuster R; Blanchard J; Edwards MJ; Lentsch AB
    J Hepatol; 2009 Aug; 51(2):296-306. PubMed ID: 19515451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
    Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
    Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
    Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
    Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins.
    Gupta N; Delrow J; Drawid A; Sengupta AM; Fan G; Gélinas C
    Cancer Res; 2008 Feb; 68(3):808-14. PubMed ID: 18245482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.
    Dutta J; Fan G; Gélinas C
    J Virol; 2008 Nov; 82(21):10792-802. PubMed ID: 18753212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.
    Rayet B; Fan Y; Gélinas C
    Mol Cell Biol; 2003 Mar; 23(5):1520-33. PubMed ID: 12588973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
    Siepe D; Jentsch S
    Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel role of Pin1 induction in type II collagen-mediated rheumatoid arthritis.
    Jeong HG; Pokharel YR; Lim SC; Hwang YP; Han EH; Yoon JH; Ahn SG; Lee KY; Kang KW
    J Immunol; 2009 Nov; 183(10):6689-97. PubMed ID: 19846884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons.
    Kesavapany S; Patel V; Zheng YL; Pareek TK; Bjelogrlic M; Albers W; Amin N; Jaffe H; Gutkind JS; Strong MJ; Grant P; Pant HC
    Mol Biol Cell; 2007 Sep; 18(9):3645-55. PubMed ID: 17626162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55.
    van der Horst A; Khanna KK
    Cancer Res; 2009 Aug; 69(16):6651-9. PubMed ID: 19638580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional conservation of phosphorylation-specific prolyl isomerases in plants.
    Yao JL; Kops O; Lu PJ; Lu KP
    J Biol Chem; 2001 Apr; 276(17):13517-23. PubMed ID: 11118438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
    Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
    Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB.
    Peloponese JM; Yasunaga J; Kinjo T; Watashi K; Jeang KT
    J Virol; 2009 Apr; 83(7):3238-48. PubMed ID: 19158244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pinning NF-kappaB to the nucleus.
    Ben-Neriah Y
    Mol Cell; 2003 Dec; 12(6):1344-5. PubMed ID: 14690587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.
    Nakatsu Y; Sakoda H; Kushiyama A; Zhang J; Ono H; Fujishiro M; Kikuchi T; Fukushima T; Yoneda M; Ohno H; Horike N; Kanna M; Tsuchiya Y; Kamata H; Nishimura F; Isobe T; Ogihara T; Katagiri H; Oka Y; Takahashi S; Kurihara H; Uchida T; Asano T
    J Biol Chem; 2011 Jun; 286(23):20812-22. PubMed ID: 21454638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T
    J Pathol; 2010 Dec; 222(4):410-20. PubMed ID: 20922712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.